Showing results (11-20 of 4,509) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trialAlessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.
Future Oncology (London, England)|May 28, 2021
Real-world time on treatment with immuno-oncology therapy in recurrent/metastatic head and neck squamous cell carcinomaKarthik Ramakrishnan, Zhiwen Liu, Shrujal Baxi, et al.
Future Oncology (London, England)|May 28, 2021
Role of nutritional care and general guidance for patients with advanced or metastatic gastric cancerTakuro Mizukami, Yongzhe Piao
Future Oncology (London, England)|July 14, 2021
Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USAAhmed Shelbaya, John M Kelton, Jeffrey Thompson, et al.
Future Oncology (London, England)|June 16, 2022
Real-world febrile neutropenia rates with same-day versus next-day pegfilgrastim after myelosuppressive chemotherapyKyle Kitchen, Michael C Mosier
Future Oncology (London, England)|June 22, 2021
Sorafenib and hepatocellular carcinoma: is alpha-fetoprotein a biomarker predictive of tumor biology and primary resistance?Francesca Negri, Letizia Gnetti, Giuseppe Pedrazzi, et al.
Future Oncology (London, England)|June 22, 2021
A review of emerging and non-US FDA-approved topical agents for the treatment of basal cell carcinomaNatalie Kash, Sirunya Silapunt
Future Oncology (London, England)|January 9, 2023
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language SummaryPaul M Barr, Carolyn Owen, Tadeusz Robak, et al.
Future Oncology (London, England)|December 15, 2022
The role of miRNA-128 in the development and progression of gastrointestinal and urogenital cancerGhaidaa Raheem Lateef Al-Awsi, Saade Abdalkareem Jasim, Yasser Fakri Mustafa, et al.
Future Oncology (London, England)|December 19, 2022
Current treatment landscape of pancreatic cancer patients in a network of office-based oncologists in GermanySusanna Hegewisch-Becker, Karsten Kratz-Albers, Jan Wierecky, et al.
Pageof 451